JHS Svendgaard Laboratories has informed that a meeting of the Board of Directors of the company is scheduled to be held on Tuesday, the 30th day of May, 2023 at 12:30 pm to consider and approve the Audited Standalone & Consolidated Financial Results for the quarter and year ended March 31, 2023. Further, in compliance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company’s Code of Conduct for prevention of Insider Trading under the provision of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company had already been closed for the insiders covered under the code from April 01, 2023 till the expiry of 48 hours after the declaration of such financial results.
The above information is a part of company’s filings submitted to BSE.
